Tuesday, 20 October 20269:00 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Immune drug anifrolumab linked to lower risk of infection and hospitalization for skin lupus: Study

Image: Business Medical Dialogues. Rights remain with the publisher.

Preliminary results from an investigator-initiated single-site clinical study show that some people with chronic cutaneous lupus erythematosus-a type of lupus that can cause permanent skin damage and...

Read the full report on Business Medical Dialogues

Story file

Section
Health
First reported by
Business Medical Dialogues
Reporter
dr. kamal kant kohli
Published
Tuesday, 20 October 2026, 7:15 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Business Medical Dialogues with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all